Health-care access for migrants in France

Celeyran, Florence Tapié de; Girardeau, Yannick; Khan, Sylvie; Morinet, F.; Georges-Tarragano, Claire

doi:10.1016/s0140-6736(13)62402-2

Cited by 8 publications

(7 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Véritable loupe grossissante des tensions qui traversent les systèmes de soins, les PASS constituent également un observatoire de ses limites et un espace de réflexion unique dans les établissements de santé [11].…”

Section: Un Espace De Réflexion Sur Les Pratiques Et De Réflexion éThunclassified

Les permanences d’accès aux soins de santé (PASS) : tradition d’hospitalité et modèle d’organisation innovante

Georges-Tarragano

2015

La Revue de Médecine Interne

View full text Add to dashboard Cite

Section: Un Espace De Réflexion Sur Les Pratiques Et De Réflexion éThunclassified

Les permanences d’accès aux soins de santé (PASS) : tradition d’hospitalité et modèle d’organisation innovante

Georges-Tarragano

2015

La Revue de Médecine Interne

View full text Add to dashboard Cite

“…The migrant population was estimated to be 22.3 million in the EU in 2017 [ 1 ] and 7.9 million in France in 2015 [ 3 ]. The first-time asylum seekers in the EU in 2018 came mostly from Syria, Afghanistan, and Iraq [ 4 ], all countries with recent or ongoing conflicts.…”

Section: Introductionmentioning

confidence: 99%

“…In France, fee exemption statuses are available to help those on a low-income, including precarious migrants, attend usual general practice. They can also receive free dedicated medical and social assistance in the hospital setting [ 6 ]. In addition, several humanitarian organizations, such as the NGO Médecins du Monde (MdM), provide primary care to this population.…”

Section: Introductionmentioning

confidence: 99%

Health Profile of Precarious Migrants Attending the Médecins Du Monde’s Health and Social Care Centres in France: a Cross-Sectional Study

Halley¹,

Giai²,

Chappuis³

et al. 2021

Int J Public Health

View full text Add to dashboard Cite

Objective: The present study aimed to compare the precarious migrants’ health problems managed in Médecins du Monde’s health and social care centres (CASO) with those of patients attending general practice in France.Methods: We compared the most frequent health problems managed in the 19 CASO in metropolitan France with those of a national sample of usual general practice consultations, after standardisation for age and sex.Results: Precarious migrants had fewer health problems managed per consultation than other patients (mean: 1.31 vs. 2.16), and these corresponded less frequently to chronic conditions (21.3% vs. 46.8%). The overrepresented health problems among CASO consultations were mainly headache (1.11% vs. 0.45%), viral hepatitis (1.05% vs. 0.20%), type 1 diabetes (1.01% vs. 0.50%) and teeth/gum disease (1.01% vs. 0.23%). Their underrepresented health problems were mainly lipid disorder (0.39% vs. 8.20%), depressive disorder (1.36% vs. 5.28%) and hypothyroidism (0.50% vs. 3.08%). Prevention issues were nominal in precarious migrants (0.16%).Conclusion: Both chronic somatic and mental conditions of precarious migrants are presumably underdiagnosed. Their screening should be improved in primary care.

show abstract

“…PASSs are hospital‐based units providing primary care services to patients with no healthcare insurance coverage 10 . These centers were created to help French populations living in precarity, in particular migrants 11 …”

Section: Introductionmentioning

confidence: 99%

“…10 These centers were created to help French populations living in precarity, in particular migrants. 11…”

Section: Introductionmentioning

confidence: 99%

Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016—1Q2021

Chappuy

Nourredine

Clerc

et al. 2021

Fundamemntal Clinical Pharma

View full text Add to dashboard Cite

Background Gabapentinoids (i.e., gabapentin and pregabalin) are medications approved for epilepsy, chronic pain, or generalized anxiety disorder. Recently, there have been regular reports of misuse of pregabalin, and to a lesser extent, gabapentin, in particular among opioid and polydrug users. Objectives To longitudinally explore the amounts of gabapentinoids dispensed in Lyon's Permanent Access to Healthcare (PASS) units, which offer permanent and free healthcare to precarious populations with no healthcare insurance coverage. Methods We collected the amounts of pregabalin and gabapentin dispensed in the three PASS units of Lyon and calculated the average doses dispensed monthly between 2016 and the first quarter of 2021 (1Q2021), with and without adjustment for the number of dispensing visits. Results The total doses of gabapentinoid dispensed every month in Lyon's PASS units displayed a 1233% increase for pregabalin, and a 1185% increase for gabapentin, between 2016 and 1Q2021. When adjusted for the number of visits, this increase reached a factor of 8.5 for pregabalin and 8.3 for gabapentin, respectively. However, while the increase in pregabalin dispensing was constant throughout the study period, gabapentin total dispensed doses were more fluctuating over time, and the rise of dispensations was thus less straightforward. Conclusion Our study reveals a local but substantial increase in gabapentinoid use in populations with no social insurance. These findings should be confirmed more widely and plead for the systematic collection of anonymous patient data in free healthcare centers in France.

show abstract

Health-care access for migrants in France

Cited by 8 publications

References 1 publication

Les permanences d’accès aux soins de santé (PASS) : tradition d’hospitalité et modèle d’organisation innovante

Les permanences d’accès aux soins de santé (PASS) : tradition d’hospitalité et modèle d’organisation innovante

Health Profile of Precarious Migrants Attending the Médecins Du Monde’s Health and Social Care Centres in France: a Cross-Sectional Study

Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016—1Q2021

Contact Info

Product

Resources

About